Screening for TK domain (exons 18-21; Supplementary figure S2A) documented that 19.8% of lung adenocarcinomas were EGFR-mutated, mostly in 19 and 21 exons, according to the literature [20,21]. The gene discussed is EGFR; the disease is lung adenocarcinoma.